Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 9/20 | 0.40 |
| ▸ | EGFR | P00533 | 3/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 2/20 | 0.38 |
| ▸ | ABL2 | P42684 | 2/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | RET | P07949 | 2/20 | 0.35 |
| ▸ | KDR | P35968 | 2/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
| ▸ | KIT | P10721 | 2/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30582562 | 1.00 | SRC (0.40) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL31219425 | 0.91 | SRC (0.40) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL30582563 | 0.90 | SRC (0.36) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL26109332 | 0.90 | SRC (0.36) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL30582567 | 0.90 | SRC (0.36) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL26105703 | 0.90 | SRC (0.36) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL30582595 | 0.89 | SRC (0.39) | SRCEGFRABL1ABL2TGFBR1 | |
| SCHEMBL26110909 | 0.89 | SRC (0.39) | SRCEGFRABL1ABL2TGFBR1 | |
| SCHEMBL30582566 | 0.88 | KIT (0.46) | SRCEGFRMAP4K4ABL1ABL2 | |
| SCHEMBL26107573 | 0.88 | KIT (0.46) | SRCEGFRMAP4K4ABL1ABL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024091370-A1 | 5,6-FUSED BICYCLIC HETEROAROMATIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | disclosed |